Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
3 Exceptional Stocks to Build Long-Term Wealth
05:25pm, Monday, 06'th Oct 2025
Blue-chip stocks come to mind. The companies behind these stocks are mature that generate significant profits that they return to shareholders in the form of buybacks and dividends.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
AbbVie Stock on the Move: What Sparked the 6% Jump in the Past Week?
11:16am, Monday, 06'th Oct 2025
ABBV shares rose 6% last week as optimism swept the pharma sector after Pfizer's landmark drug-pricing deal with the Trump administration.
OnabotulinumtoxinA (BOTOX®) met the primary endpoint in the Phase 2 trial, demonstrating a statistically significant improvement from baseline in the Tremor Disability Scale-Revised (TREDS-R) total u
Top Dividend Stocks Poised for Explosive Growth in 2026 (ABBV, GD, RGR)
10:01am, Saturday, 04'th Oct 2025
Geopolitical events, judicial rulings, new law legislation, and policy changes are all circumstances occurring on domestic and international stages that are triggering big stock moves in various indus
AbbVie expects $2.7 billion R&D charge in third quarter
04:16pm, Friday, 03'rd Oct 2025
Drugmaker AbbVie in a regulatory filing on Friday said it expects third-quarter earnings to include a $2.7 billion charge related to in-process research and development (IPR&D) expenses.
St Louis Financial Loads Up on AbbVie (ABBV) With 14,600 Shares Buy
02:50pm, Friday, 03'rd Oct 2025
St. Louis Financial Planners Asset Management, LLC initiated a new stake in AbbVie (ABBV -0.78%), acquiring 14,630 shares for an estimated $3.39 million in Q3 2025.
AbbVie: Wins Accumulating While We Wait For Next BD Steps
11:05am, Friday, 03'rd Oct 2025
AbbVie is outperforming expectations with strong commercial results, pipeline progress, and the legal win that secured Rinvoq's long-term market exclusivity. ABBV has raised the full-year revenue guid
AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why
06:45pm, Thursday, 02'nd Oct 2025
In the closing of the recent trading day, AbbVie (ABBV) stood at $236.56, denoting a -3.2% move from the preceding trading day.
ABBV Stock vs. Eli Lilly & Merck
08:20am, Thursday, 02'nd Oct 2025
AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision
AbbVie to Host Third-Quarter 2025 Earnings Conference Call
08:00am, Thursday, 02'nd Oct 2025
NORTH CHICAGO, Ill. , Oct. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its third-quarter 2025 financial results on Friday, October 31, 2025, before the market opens.
Why AbbVie Stock Cruised to an Almost 6% Gain Today
06:36pm, Wednesday, 01'st Oct 2025
The announcement of a new buildout, as well as developments on the political front, were the factors driving up AbbVie (ABBV 5.54%) stock on Wednesday. The pharmaceutical company's shares rose by near
Natrelle® Awarded Supplier Agreement from Vizient
08:00am, Wednesday, 01'st Oct 2025
This agreement grants Vizient clients enhanced access to Natrelle®, the broadest selection of breast implant options on the market. IRVINE, Calif.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
05:25am, Wednesday, 01'st Oct 2025
Stocks in the S&P 500 (^GSPC 0.41%) offer a miserly yield of 1.2% (on average) today. You can do way better than that and still invest in very attractive businesses.
AbbVie Begins Construction on $70 Million Expansion to Further Increase Biologics Manufacturing and R&D Presence in the U.S.
03:00pm, Tuesday, 30'th Sep 2025
Expansion increases biologics manufacturing for immunology and oncology medicines Milestone marks progress on AbbVie's long-term commitment to U.S. manufacturing Furthers longstanding commitment to Ab
